Logo - springer
Slogan - springer

Biomedical Sciences - Medical Microbiology | Fibrinolytic Bacterial Enzymes with Thrombolytic Activity

Fibrinolytic Bacterial Enzymes with Thrombolytic Activity

Kotb, Essam

2012, XII, 74p. 15 illus., 6 illus. in color.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$39.95

(net) price for USA

ISBN 978-3-642-24980-8

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$49.95

(net) price for USA

ISBN 978-3-642-24979-2

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • About this book

  • Integrated practical and theoretical trends
  • Describes fibrinolytic microbial enzymes for clinical applications
  • Provides an outlook to future research

Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest.

The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today’s research.

Content Level » Research

Keywords » Blood clots - Streptokinase - Thrombosis

Related subjects » Cardiology & Angiology - Human Physiology - Internal Medicine - Medical Microbiology

Table of contents / Sample pages 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Medical Microbiology.